IP Verse

Use Of Cannabidiol In The Treatment Of Tuberous Sclerosis Complex - EP3641819

The patent EP3641819 was granted to GW Research on Oct 11, 2023. The application was originally filed on Jun 21, 2018 under application number EP18737374A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3641819

GW RESEARCH
Application Number
EP18737374A
Filing Date
Jun 21, 2018
Status
Granted And Under Opposition
Sep 8, 2023
Grant Date
Oct 11, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBJul 9, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONUS2016367496
INTERNATIONAL-SEARCH-REPORTCN104490873
INTERNATIONAL-SEARCH-REPORTWO2013168131
INTERNATIONAL-SEARCH-REPORTWO2016191651
INTERNATIONAL-SEARCH-REPORTWO2017204986
INTERNATIONAL-SEARCH-REPORTWO2018002637
INTERNATIONAL-SEARCH-REPORTWO2018002665
OPPOSITIONUS2016166515
OPPOSITIONWO2016191651

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "INNOVATING THROUGH PARTNERSHIPS", 2017 International Research Conference on TSC and LAM: Innovating Through Partnerships, (20170622), XP093195595-
OPPOSITION- Da Silva Serra Inês , "The Effect of Cannabidiol in Tuberous Sclerosis Complex", Thesis, (20190401), pages 1 - 182, XP093241933-
OPPOSITION- Ho Calvin N., Gabrielle Rushing, James E. Valentine, Kari Luther Rosbeck, Steven L. Roberds, "The Voice of the Patient - A Report from the Tuberous Sclerosis Alliance’s Externally-Led Patient-Focused Drug Development Meeting", Tuberous Sclerosis Alliance, (20171026), Tuberous Sclerosis Alliance, URL: https://www.tscalliance.org/wp-content/uploads/2018/01/Voice-of-the-Patient-Tuberous-Sclerosis-Alliance.pdf, XP093195598-
OPPOSITION- Leung, A.K.C. Robson, W.L.M., "Tuberous Sclerosis Complex: A Review", Journal of Pediatric Health Care, AMSTERDAM, NL , (20070223), vol. 21, no. 2, doi:10.1016/j.pedhc.2006.05.004, ISSN 0891-5245, pages 108 - 114, XP005898717
OPPOSITION- Krueger Darcy A., Et Al., "Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference", Pediatric Neurology, ELSEVIER SCIENCE., NL, NL , (20131001), vol. 49, no. 4, doi:10.1016/j.pediatrneurol.2013.08.002, ISSN 0887-8994, pages 255 - 265, XP093195601
OPPOSITION- Evan J. Hess; Kirsten A. Moody; Alexandra L. Geffrey; Sarah F. Pollack; Lauren A. Skirvin; Patricia L. Bruno; Jan L. Paolini; Elizabeth A. Thiele, "Cannabidiol as a new treatment for drug‐resistant epilepsy in tuberous sclerosis complex", Epilepsia, Raven press LTD, New York , US, New York , US , (20161003), vol. 57, no. 10, doi:10.1111/epi.13499, ISSN 0013-9580, pages 1617 - 1624, XP071213053
OPPOSITION- A. Shrivastava, P. M. Kuzontkoski, J. E. Groopman, A. Prasad, "Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy", Molecular Cancer Therapeutics, American Association for Cancer Research, US, US , (20110701), vol. 10, no. 7, doi:10.1158/1535-7163.MCT-10-1100, ISSN 1535-7163, pages 1161 - 1172, XP055418898
OPPOSITION- Franz David N., Capal Jamie K., "mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders", Orphanet Journal of Rare Diseases, BioMed Central Ltd, Lo, Lo , (20171201), vol. 12, no. 51, doi:10.1186/s13023-017-0596-2, ISSN 1750-1172, XP093195599
OPPOSITION- Kalenderoglou Nikoletta, Macpherson Tara, Wright Karen L., "Cannabidiol Reduces Leukemic Cell Size - But Is It Important?", Frontiers in pharmacology, Frontiers Research Foundation, CH, CH , vol. 8, doi:10.3389/fphar.2017.00144, ISSN 1663-9812, XP093195605

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents